Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M800367-JLR200 on December 15, 2008

Papers In Press, published online ahead of print October 1, 2009
J. Lipid Res., doi:10.1194/jlr.M800367-JLR200
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M800367-JLR200v1
50/10/1986    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wijesinghe, D. S.
Right arrow Articles by Chalfant, C. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wijesinghe, D. S.
Right arrow Articles by Chalfant, C. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 50, 1986-1995, October 2009
Copyright © 2009 by American Society for Biochemistry and Molecular Biology

Chain length specificity for activation of cPLA2{alpha} by C1P: use of the dodecane delivery system to determine lipid-specific effects

Dayanjan S. Wijesinghe*, Preeti Subramanian*, Nadia F. Lamour*, Luciana B. Gentile*, Maria H. Granado{dagger}, Alicja Bielawska§, Zdzislaw Szulc§, Antonio Gomez-Munoz{dagger} and Charles E. Chalfant1,***,{dagger}{dagger}

* Department of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, Richmond, VA
{dagger} Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country
§ Department of Biochemistry & Molecular Biology, Medical University of South Carolina, Charleston, SC
*** Research and Development, Hunter Holmes McGuire Veterans Administration Medical Center, Richmond, VA
{dagger}{dagger} Research and Development, The Massey Cancer Center, Richmond, VA

1 To whom correspondence should be addressed. e-mail: cechalfant{at}vcu.edu

Previously, our laboratory demonstrated that ceramide-1-phosphate (C1P) specifically activated group IVA cytosolic phospholipase A2 (cPLA2{alpha}) in vitro. In this study, we investigated the chain length specificity of this interaction. C1P with an acyl-chain of ≥6 carbons efficiently activated cPLA2{alpha} in vitro, whereas C2-C1P, was unable to do so. Delivery of C1P to cells via the newly characterized ethanol/dodecane system demonstrated a lipid-specific activation of cPLA2{alpha}, AA release, and PGE2 synthesis (EC50 = 400 nM) when compared to structurally similar lipids. C1P delivered as vesicles in water also induced a lipid-specific increase in AA release. Mass spectrometric analysis demonstrated that C1P delivered via ethanol/dodecane induced a 3-fold increase in endogenous C1P with little metabolism to ceramide. C1P was also more efficiently delivered (>3-fold) to internal membranes by ethanol/dodecane as compared to vesiculated C1P. Using this now established delivery method for lipids, C2-C1P was shown to be ineffective in the induction of AA release as compared with C6-C1P, C16-C1P, and C18:1 C1P. Here, we demonstrate that C1P requires ≥6 carbon acyl-chain to activate cPLA2{alpha}. Thus, published reports on the biological activity of C2-C1P are not via eicosanoid synthesis. Furthermore, this study demonstrates that the alcohol/dodecane system can be used to efficiently deliver exogenous phospholipids to cells for the examination of specific biological effects.—Wijesinghe, D. S., P. Subramanian, N. F. Lamour, L. B. Gentile, M. H. Granado, A. Bielawska, Z. Szulc, A. Gomez-Munoz, and C. E. Chalfant. Chain length specificity for activation of cPLA2{alpha} by C1P: use of the dodecane delivery system to determine lipid-specific effects.

Supplementary key words ceramide-1-phosphate • ceramide kinase • prostaglandins • phospholipase A2 • inflammation • arachidonic acid • dodecane • eicosanoids

Abbreviations: AA, arachidonic acid; CERK, ceramide kinase; C1P, ceramide-1-phosphate; cPLA2{alpha}, group IVA cytosolic phospholipase A2; EtOH, ethanol; GFP, green fluorescent protein; PA, phosphatidic acid; PAPC, 1-palmitoyl-2-arachidonoylphosphotidylcholine; PC, phosphatidylcholine; PDI, protein disulfide isomerase; PGE2, prostaglandin E2; SMase, sphingomyelinase


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement